Stoke Therapeutics, Inc. (STOK)
30.05
+0.24
(+0.81%)
USD |
NASDAQ |
Sep 08, 16:00
29.60
-0.45
(-1.50%)
After-Hours: 07:26
Stoke Therapeutics Price : 30.05 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 29.13 | 30.68 | 28.88 | 30.05 | 680963.0 |
| Sep 04, 2026 | 29.41 | 30.03 | 29.14 | 29.81 | 714062.0 |
| Sep 03, 2026 | 30.70 | 30.70 | 29.69 | 29.99 | 512255.0 |
| Sep 02, 2026 | 31.46 | 32.12 | 29.98 | 30.50 | 631318.0 |
| Sep 01, 2026 | 29.94 | 31.38 | 29.94 | 30.89 | 727504.0 |
| Aug 31, 2026 | 31.37 | 32.18 | 30.58 | 31.20 | 1.116M |
| Aug 28, 2026 | 32.20 | 32.55 | 31.49 | 31.62 | 754099.0 |
| Aug 27, 2026 | 33.01 | 33.18 | 32.00 | 32.59 | 939340.0 |
| Aug 26, 2026 | 33.21 | 33.55 | 32.57 | 33.09 | 1.155M |
| Aug 25, 2026 | 32.70 | 33.94 | 32.45 | 33.46 | 728630.0 |
| Aug 24, 2026 | 32.29 | 32.76 | 31.16 | 32.32 | 562290.0 |
| Aug 21, 2026 | 31.76 | 32.76 | 31.52 | 32.29 | 1.274M |
| Aug 20, 2026 | 32.48 | 32.59 | 29.86 | 31.40 | 1.485M |
| Aug 19, 2026 | 32.75 | 33.43 | 32.52 | 33.03 | 1.472M |
| Aug 18, 2026 | 31.85 | 32.67 | 31.40 | 32.14 | 574554.0 |
| Aug 17, 2026 | 31.09 | 32.52 | 31.09 | 32.13 | 444657.0 |
| Aug 14, 2026 | 31.70 | 31.70 | 30.20 | 31.27 | 495116.0 |
| Aug 13, 2026 | 33.28 | 33.28 | 31.15 | 31.31 | 480972.0 |
| Aug 12, 2026 | 32.94 | 33.56 | 32.05 | 32.97 | 977978.0 |
| Aug 11, 2026 | 32.18 | 33.04 | 31.23 | 32.96 | 1.309M |
| Aug 10, 2026 | 32.41 | 32.83 | 32.00 | 32.23 | 424665.0 |
| Aug 07, 2026 | 32.00 | 32.84 | 31.62 | 32.71 | 866579.0 |
| Aug 06, 2026 | 31.99 | 33.09 | 31.60 | 31.93 | 691032.0 |
| Aug 05, 2026 | 32.03 | 32.85 | 31.33 | 31.93 | 635025.0 |
| Aug 04, 2026 | 28.78 | 32.99 | 28.78 | 31.67 | 1.320M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 212.50 |
| Agenus, Inc. | 7.43 |
| Amgen, Inc. | 393.17 |
| Anika Therapeutics, Inc. | 21.04 |
| BioCryst Pharmaceuticals, Inc. | 9.065 |
Price Related Metrics
| PS Ratio | 67.01 |
| Price to Book Value | 5.427 |
| Earnings Yield | -11.22% |
| Market Cap | 1.875B |